Vascular aspects of multiple sclerosis

  title={Vascular aspects of multiple sclerosis},
  author={Miguel D’haeseleer and Melissa Cambron and Ludo Vanopdenbosch and Jacques De Keyser},
  journal={The Lancet Neurology},

Figures and Tables from this paper

Cerebral Hypoperfusion: A New Pathophysiologic Concept in Multiple Sclerosis?

Evidence is evolving that cerebral hypoperfusion in MS is associated with chronic hypoxia, focal lesion formation, diffuse axonal degeneration, cognitive dysfunction, and fatigue, and Restoring CBF may emerge as a new therapeutic target in MS.

Cerebrovascular Reactivity in Multiple Sclerosis

The results of the studies assessing vasoneuronal coupling in MS patients have showed hyperactivity at the occipital region to visual stimulation during attack, but not attack free period of the disease suggesting that demyelinization and axonal degeneration leads the surviving neurons hyperactive.

Age‐related small vessel disease: a potential contributor to neurodegeneration in multiple sclerosis

Several lines of evidence suggest that an interaction between MS and SVD may influence MS‐related neurodegeneration, and therapeutic agents targeting the microvasculature and the neurovascular unit may impact both SVD and MS and may benefit patients with dual pathology.

The Role of Cerebral Hypoperfusion in Multiple Sclerosis (ROCHIMS) Trial in Multiple Sclerosis: Insights From Negative Results

This study showed that CBF in RRMS patients is not always decreased and that bosentan has no effect when CBF values are within the normal range, and hypothesize that in patients there was no significant astrocytic production of ET-1 because they had a mild disease course, with minimal local inflammatory activity.

Role of astrocytes in pathogenesis of multiple sclerosis and their participation in regulation of cerebral circulation.

It appears that complications of cardiovascular disease development precede progressive loss of axons, which mechanisms are complex and should be linked to a loss of β2 adrenergic receptors on astrocytes of demyelinating lesions.

Vascular pathology of multiple sclerosis

The purpose of this issue of Neurological Research is to synthesize current concepts and most recent findings concerning the evaluation, pathogenesis, and clinical relevance of the vascular pathology of MS.

The Evidence for Hypoperfusion as a Factor in Multiple Sclerosis Lesion Development

  • B. Juurlink
  • Medicine, Biology
    Multiple sclerosis international
  • 2013
It is important that clinical trials addressing vascular issues in MS should examine how the vascular intervention affects white matter perfusion and determine whether the extent of perfusion recovery and maintenance of this recovery is related to functional recovery and Maintenance of functional recovery.

Cerebral hemodynamics in patients with multiple sclerosis.

Characteristics of cerebral blood flow in an Eastern sample of multiple sclerosis patients: A potential quantitative imaging marker associated with disease severity

The results indicated that MS patients with strongly increasedCBF showed worse disease severity, including higher Expanded Disability Status Scale (EDSS) scores and serum neurofilament light chain (sNfL) values than those with mildly increased CBF, and imply that CBF could be a potential quantitative imaging marker associated with disease severity.



Hypoperfusion of the Cerebral White Matter in Multiple Sclerosis: Possible Mechanisms and Pathophysiological Significance

  • J. De KeyserC. SteenJ. MostertM. Koch
  • Medicine, Biology
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
  • 2008
Pathologic and imaging studies suggest that ischemic changes might be involved in the development of a subtype of focal demyelinating lesions (type III lesions), and there appears to exist a relationship between decreased white matter perfusion and cognitive dysfunction in patients with MS.

Anomalous Venous Blood Flow and Iron Deposition in Multiple Sclerosis

  • A. V. SinghP. Zamboni
  • Medicine, Psychology
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
  • 2009
The hypothesis that iron deposits in MS are a consequence of altered cerebral venous return and chronic insufficient venous drainage is supported and several recently published studies support the hypothesis that MS progresses along the venous vasculature.

Chronic cerebrospinal venous insufficiency and multiple sclerosis

The recent investigations that led to the description of CCSVI are discussed as well as the conceptual and technical shortcomings that challenge the potential relationship of this phenomenon to MS.

Multiple sclerosis appears To be associated with cerebral venous abnormalities

The results of the study clearly show that when upright, the average flow through the internal jugular veins of the MS patients was over twice that in the control group, and analysis of the data reveals that the blood flow rate was 2.5 times greater than that of the healthy controls, despite the fact that the cross-sectional area of the IJVs was no greater.

Hypoperfusion of brain parenchyma is associated with the severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis: a cross-sectional preliminary report

This pilot study is the first to report a significant relationship between the severity of CCSVI and hypoperfusion in the brain parenchyma, and this findings should be confirmed in a larger cohort of MS patients to ensure that they generalize to the MS population as a whole.

Plasma homocysteine levels in multiple sclerosis

Elevated plasma homocysteine occurs in both benign and progressive disease courses of MS, and seems unrelated to immune activation, oxidative stress, or a deficiency in vitamin B6, vitamin B12, or folate.

The Immunopathology of Multiple Sclerosis: An Overview

Recent evidence is described that the spectrum of MS pathology is much broader, including demyelination in the cortex and deep gray matter nuclei, as well as diffuse injury of the normal‐appearing white matter.

["Chronic cerebrospinal venous insufficiency" and multiple sclerosis: critical analysis and first observation in an unselected cohort of MS patients].

The authors conclude that the "chronic cerebrospinal venous insufficiency (CCSVI)" cannot represent the exclusive pathogenetic factor in the pathogenesis of MS, and cannot justify invasive "therapeutic" approaches if they are performed outside of clinical trials.